Inventor

GRIFFIN JOHN H

US48 patents

⚠️ This page may combine multiple inventors who share the name “GRIFFIN JOHN H”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GRIFFIN JOHN H

THERAVANCE INC

Muscarinic receptor antagonists

Multivalent macrolide antibiotics

Sodium channel drugs and uses

Derivatives of glycopeptide antibacterial agents

H1—histamine receptor antagonists

Calcium channel drugs and uses

Protein kinase inhibitors

Indolinone derivatives

Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same

Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same

Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same

Multivalent macrolide antibiotics

Muscarinic receptor antagonists

Protein kinase inhibitors

Protein kinase inhibitors

Indolinone derivatives

Indolinone derivatives

Antibacterial agents

Calcium channel drugs and uses

SCRIPPS RESEARCH INST

Assay methods for detecting serum proteases, particularly activated protein C

Serine protease derived-polypeptides and anti-peptide antibodies, systems and therapeutic methods for inhibiting coagulation

Activated protein C polypeptides and anti-peptide antibodies, diagnostic methods and systems for inhibiting activated protein C

Method for diagnosis of thrombotic disorders

Method for diagnosis of thrombotic disorders

Method for diagnosis of thrombotic disorders

Neuroprotective, antithrombotic and anti-inflammatory uses of activated protein C (APC)

Protein S polypeptides and anti-peptide antibodies that inhibit protein S binding to C4B binding protein, diagnostic systems and therapeutic methods

Activated protein C variants with normal cytoprotective activity but reduced anticoagulant activity

Stabilized proteins with engineered disulfide bonds

Recombinant protein S variants deficient in C4BP binding activity, compositions and therapeutic methods

Method for detecting the presence of protein C antibody in a fluid sample

Method for diagnosis of thrombotic disorders

Stabilized proteins with engineered disulfide bonds

Protease activated receptor-1 (PAR1) derived cytoprotective polypeptides and related methods

Protease Activated Receptor-1 (PAR1) Derived Cytoprotective Polypeptides and Related Methods

ADVANCED MEDICINE INC

Multibinding inhibitors of microsomal triglyceride transferase protein

β2- adrenergic receptor agonists

Multibinding inhibitors of cyclooxygenase-2

Multivalent polymyxin antibiotics

Sodium channel drugs and uses

Analgesic agents

Multibinding inhibitors of HMG-CoA reductase

SCRIPPS CLINIC RES

Inhibition of arterial thrombotic occlusion or thromboembolism

Inhibition of arterial thrombotic occlusion or thromboembolism

(unassigned)

Plasma glucosylceramide deficiency as risk factor for thrombosis and modulator of anticoagulant protein C

UNIV CALIFORNIA

Therapy for treatment or prevention of conditions associated with bleeding or hypocoagulation

GRIFFIN JOHN H

Activated protein C variants with normal cytoprotective activity but reduced anticoagulant activity

SOCRATECH L L C

Protein S protects the nervous system from injury